Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells

Blood

Volumn 93, Issue 7, 1999, Pages 2319-2326

  Carbone, Antonino ^a   Gloghini, Annunziata ^b   Larocca, Luigi M ^b   Antinori, Andrea ^b   Falini, Brunangelo ^b   Tirelli, Umberto ^b   Dalla Favera, Riccardo ^b   Gaidano, Gianluca ^b  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GLYCOPROTEIN GP 39; LATENT MEMBRANE PROTEIN 1; PROTEOGLYCAN; SYNDECAN; TRANSCRIPTION FACTOR;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; GERMINAL CENTER; HISTOGENESIS; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; LYMPH NODE BIOPSY; PRIORITY JOURNAL; REED STERNBERG CELL;

ANTIGENS, CD40; B-LYMPHOCYTES; CD40 LIGAND; CELL COMMUNICATION; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS INFECTIONS; GERMINAL CENTER; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; LYMPHOMA, AIDS-RELATED; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-6; REED-STERNBERG CELLS; SYNDECAN-1; SYNDECANS; T-LYMPHOCYTES; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELLS; VIRAL MATRIX PROTEINS;

EID: 0033120451     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Serraino D, Pezzotti P, Dorrucci M, Alliegro MB, Sinicco A, Rezza G: Cancer incidence in a cohort of human immunodeficiency virus seroconverters. HIV Italian Seroconversion Study Group. Cancer 79:1004, 1997
2. Goedert JJ, Coté TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, Jaffe ES, Biggar RJ, for the AIDS-Cancer Match Study Group: Spectrum of AIDS-associated malignant disorders. Lancet 351:1833, 1998
3. Tirelli U, Errante D, Dolcetti R, Gloghini A, Serraino D, Vaccher E, Franceschi S, Boiocchi M, Carbone A: Hodgkin's disease and human immunodeficiency virus infection: Clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol 13:1758, 1995
4. Ree HJ, Strauchen JA, Khan AA, Gold JE, Crowley JP, Khan H, Zalusky R: Human immunodeficiency virus-associated Hodgkin's disease. Clinicopathologic studies of 24 cases and preponderance of mixed cellularity type characterized by the occurrence of fibrohistiocytoid stromal cells. Cancer 67:1614, 1991
5. Uccini S, Monardo F, Ruco LP, Baroni CD, Faggioni A, Agliano AM, Gradilone A, Manzari V, Vago L, Costanzi G, Carbone A, Boiocchi M, De Re V: High frequency of Epstein-Barr virus genome in HIV-positive patients with Hodgkin's disease. Lancet 1:1458, 1989
6. Audouin J, Diebold J, Pallesen G: Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients. J Pathol 167:381, 1992
7. Herndier BG, Sanchez HC, Chang KL, Chen YY, Weiss LM: High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of HIV-associated Hodgkin's disease. Am J Pathol 142:1073, 1993
8. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 67: Human Immunodeficiency Viruses and Human T-Cell Lymphotropic Viruses. International Agency for Research on Cancer/ World Health Organization, Lyon, France, 1996
9. Unger P, Strauchen JA: Hodgkin's disease in AIDS complex patients. Report of four cases and tissue immunologic marker studies. Cancer 58:821, 1986
10. Knowles DM, Chamulak GA, Subar M, Burke JS, Dugan M, Wenz J, Slywotzky C, Pelicci P-G, Dalla-Favera R, Raphael B: Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 108:744, 1988
11. Pelstring RJ, Zellmer RB, Sulak LE, Banks PM, Clare N: Hodgkin's disease in association with human immunodeficiency virus infection. Pathologic and immunologic features. Cancer 67:1865, 1991
12. Küppers R, Rajewsky K, Zhao M, Simons G, Laumann R, Fischer R, Hansmann M-L: Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA 91:10962, 1994
13. Hummel M, Ziemann K, Lammert H, Pileri S, Sabattini E, Stein H: Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. N Engl J Med 333:901, 1995
14. Kanzler H, Küppers R, Hansmann M-L, Rajewsky K: Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 184:1495, 1996
15. Marafioti T, Hummel M, Anagnostopoulos I, Foss HD, Falini B, Delsol G, Isaacson PG, Pileri S, Stein H: Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B-cells. N Engl J Med 337:453, 1997
16. Ohno T, Stribley JA, Wu G, Hinrichs SH, Weisenburger DD, Chan WC: Clonality in nodular lymphocyte-predominant Hodgkin's disease. N Engl J Med 337:459, 1997
17. Carbone A, Gloghini A, Gaidano G, Franceschi S, Capello D, Drexler HG, Falini B, Dalla-Favera R: Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease. Blood 92:2220, 1998
18. Ye BH, Lista F, Lo Coco F, Knowles DM, Chaganti RSK, Dalla-Favera R: Alterations of BCL-6, a novel zinc-finger gene, in diffuse large cell lymphoma. Science 262:747, 1993
19. Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, de Waard R, Leung C, Nouri-Shirazi M, Orazi A, Chaganti RS, Rothman P, Stall AM, Pandolfi PP, Dalla-Favera R: The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 16:161, 1997
20. Flenghi L, Ye BH, Fizzotti M, Bigerna B, Cattoretti G, Venturi S, Pacini R, Pileri S, Lo Coco F, Pescarmona E, Pelicci P-G, Dalla-Favera R, Falini B: A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells. Am J Pathol 147:405, 1995
21. Carbone A, Gaidano G, Gloghini A, Larocca LM, Capello D, Canzonieri V, Antinori A, Tirelli U, Falini B, Dalla-Favera R: Differential expression of BCL-6, CD 138/syndecan-1 and EBV-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood 91:747, 1998
22. Allman D, Jain A, Dent A, Maile RR, Selvaggi T, Kehry MR, Staudt LM: BCL-6 expression during B-cell activation. Blood 87:5257, 1996
23. Cattoretti G, Zhang J, Cleary AM, Lederman S, Gaidano G, Carbone A, Chaganti RSK, Dalla-Favera R: Downregulation of BCL-6 gene expression by CD40 and EBV latent membrane protein-1 (LMP-1) and its block in lymphoma carrying BCL-6 rearrangements. Blood 90:175a, 1997(abstr)
24. Wijdenes J, Vooijs WC, Clément C, Post J, Morard F, Vita N, Laurent P, Sun R-X, Klein B, Dore J-M: A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. Br J Haematol 94:318, 1996
25. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
26. Lukes RJ, Craver LF, Hall TC, Rappaport H, Ruben P: Report of the Nomenclature Committee. Cancer Res 26:1311, 1966
27. Lukes RJ, Butler JJ, Hicks EB: Natural history of Hodgkin's disease as related to its pathologic picture. Cancer 19:317, 1966
28. Neiman RS: Current problems in the histopathologic diagnosis and classification of Hodgkin's disease, in Sommers SC, Rosen PP (eds): Pathology Annual. Norwalk, CT, Appleton-Century-Crofts, 1978, p 289
29. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219, 1984
30. Flenghi L, Bigerna B, Fizzotti M, Venturi S, Pasqualucci L, Pileri S, Ye BH, Gambacorta M, Pacini R, Baroni CD, Pescarmona E, Anagnostopoulos I, Stein H, Asdrubali G, Martelli MF, Pelicci P-G, Dalla-Favera R, Falini B: Monoclonal antibodies PG-B6a and PG-B6b recognize, respectively, a highly conserved and a Formol-resistant epitope on the human BCL-6 protein amino-terminal region. Am J Pathol 148:1543, 1996
31. Hsu S-M, Raine L, Fanger H: A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 75:734, 1981
32. Carbone A, Gloghini A, Volpe R: Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas. Cancer 70:2691, 1992
33. + anaplastic large cell lymphomas. Blood 83:785, 1994
34. Carbone A, Gloghini A, Gaidano G, Cilia AM, Bassi P, Polito P, Vaccher E, Saglio G, Tirelli U: AIDS-related Burkitt's lymphoma. Morphologic and immunophenotypic study of biopsy specimens. Am J Clin Pathol 103:561, 1995
35. Falini B, Bigerna B, Pasqualucci L, Fizzotti M, Martelli MF, Pileri S, Pinto A, Carbone A, Venturi S, Pacini R, Cattoretti G, Pescarmona E, Lo Coco F, Pelicci P-G, Anagnastopoulos I, Dalla-Favera R, Flenghi L: Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease. Blood 87:465, 1996
36. Gruss H-J, Hirschstein D, Wright B, Ulrich D, Caligiuri MA, Barcos M, Strockbine L, Armitage RJ, Dower SK: Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease. Blood 84:2305, 1994
37. Carbone A, Gloghini A, Gruss H-J, Pinto A: CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. Am J Pathol 147:912, 1995
38. Liebowitz D: Epstein Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. N Engl J Med 338:1413, 1998
39. Larocca LM, Capello D, Rinelli A, Nori S, Antinori A, Gloghini A, Cingolani A, Migliazza A, Saglio G, Camilleri-Broet S, Raphael M, Carbone A, Gaidano G: The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. Blood 92:1011, 1998
40. H4 genes in AIDS-associated B-cell lymphomas. Blood 88:252, 1996
41. Gaidano G, Carbone A, Pastore C, Capello D, Migliazza A, Gloghini A, Roncella S, Ferrarini M, Saglio G, Dalla-Favera R: Frequent mutation of the 5′ noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood 89:3755, 1997